Cell Therapy Market Size Set to More Than Double by 2030 -- North America Leads, While Asia-Pacific Emerges as the Fastest-Growing Region, Says Mordor Intelligence

HYDERABAD, India, Nov. 24, 2025 /PRNewswire/ -- According to Mordor Intelligence, the cell therapy market is valued at USD 5.5 billion in 2025 and is projected to surpass USD 12.2 billion by 2030, advancing at an 17.05% CAGR, driven by rising commercialization of advanced therapies, increasing investment in manufacturing capacity, and significant progress in allogeneic, off-the-shelf treatment platforms. Growing demand for personalized and regenerative treatment options, combined with regulatory support for breakthrough therapies, continues to propel the market into a high-growth phase. As biopharmaceutical companies accelerate the development of scalable and next-generation cell therapy solutions, the sector is transitioning from early-stage innovation to broader clinical and commercial integration.

Regional Market Insights

North America continues to lead the global cell therapy market due to strong regulatory pathways, advanced manufacturing infrastructure, and high investment in R&D. The United States remains at the forefront of CAR-T development, allogeneic platform research, and commercialization of next-generation therapies.

Asia-Pacific is projected to grow at the fastest pace through 2030, supported by rising clinical trial activity, cost-efficient production capabilities, and increasing government initiatives to strengthen biotechnology innovation. Countries such as China, Japan, and South Korea are accelerating approvals and expanding research ecosystems for cell-based therapies.

Emerging Key Trends

Rapid Commercialization of Autologous Therapies

Autologous therapies have gained strong clinical traction as personalized treatment solutions, especially in oncology. Their increasing regulatory approvals and expanding real-world evidence base are encouraging providers and payers to integrate these therapies into routine treatment pathways. Faster production workflows and optimized patient cell-collection methods are further improving accessibility.

Expansion Beyond Oncology into Regenerative & Immune Disorders

While oncology remains the leading application segment, cell therapy is expanding into autoimmune, cardiovascular, neurological, and musculoskeletal indications. This diversification is broadening the treatment landscape and creating new opportunities for research organizations and developers targeting unmet medical needs.

Comprehensive Market Segmentation Overview

By Therapy Type

• Autologous Cell Therapy
• Allogeneic Cell Therapy

By Cell Type

• Stem Cell Therapy
• Hematopoietic Stem Cells
• Mesenchymal Stem Cells
• Induced Pluripotent Stem Cells

 Immune Cell Therapy        

• T Cell Therapy
• NK Cell Therapy
• Dendritic Cell Therapy
• Fibroblast & Chondrocyte-based Therapies

By Application 

• Oncology
• Cardiovascular Diseases
• Orthopedic & Musculoskeletal
• Neurological Disorders
• Autoimmune Disorders
• Wound Healing & Dermatology
• Ophthalmology

By End User

• Hospitals & Clinics
• Specialty Cell- & Gene-Therapy Centers
• Academic & Research Institutes
• Contract Manufacturing & CRO Facilities

By Geography

• North America
• Europe
• Asia-Pacific
• Middle East & Africa
• South America

For a full breakdown of market size, segmentation data, and competitive intelligence, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/cell-therapy-market?utm_source=prnewswire 

Competitive Environment

The cell therapy market is moderately consolidated, with global biotechnology leaders and emerging specialists contributing to a highly competitive and innovation-driven ecosystem. Companies are prioritizing advancements in gene-modified cells, off-the-shelf therapeutic platforms, and automated production technologies. Strategic collaborations, licensing agreements, and investment in AI-enabled manufacturing are becoming key approaches to expand development pipelines and accelerate commercialization.

Key Companies in the Cell Therapy Include:

• Corestem Inc.
• Chiesi Farmaceutici S.p.A.
• Tego Science
• Allogene Therapeutics Inc.
• Takeda Pharmaceuticals

Check out related reports published by Mordor Intelligence:  

CAR T-Cell Therapy Market: The CAR T-Cell Therapy Market is Segmented by Target Antigen (CD19, BCMA, CD22, GD2), Type (Abecma, Breyanzi), Cell Source (Autologous and Allogenic), Application (Leukemia, Lymphoma), End User (Hospitals, Cancer Care Treatment Centers), and Geography (North America, Europe, Asia-Pacific).

Novartis AG, Bristol-Myers Squibb Company, Johnson & Johnson, Sorrento Therapeutics, Inc. and Gilead Sciences, Inc. (Kite Pharma) are the major companies operating in this market.

Read more about companies active in CAR T-Cell Therapy: https://www.mordorintelligence.com/industry-reports/car-t-cell-therapy/companies?utm_source=prnewswire

Cell Culture Market: The Cell Culture Market Report is Segmented by Product (Equipment and Consumables), Cell Type (Mammalian Cells), Technology (2-D Cell Culture and 3-D Cell Culture), Application (Biopharmaceutical Production, Drug Discovery & Development), End-User (Pharmaceutical & Biotechnology Companies), and Geography (North America, Europe).

Thermo Fisher Scientific, Danaher Corporation, Sartorius AG, Merck KGaA and Becton, Dickson and Company are the major companies operating in this market.

Read more about companies active in Cell Culture: https://www.mordorintelligence.com/industry-reports/cell-culture-market/companies?utm_source=prnewswire

Gene Therapy Market: The Gene Therapy Market Report Segments the Industry Into by Vector Type (Adeno Virus Vector), Indication (Oncology, Rare Metabolic Disorders, and More), Delivery Mode (In Vivo Gene Delivery and Ex Vivo Gene Delivery), End User (Hospitals and Clinics), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, South America).

About Mordor Intelligence: 
 
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. 

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. 

 For any inquiries, please contact:

media@mordorintelligence.com   
https://www.mordorintelligence.com/contact-us

Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg

SOURCE Mordor Intelligence Private Limited